Brain tumours repurpose endogenous neuron to microglia signalling mechanisms to promote their own proliferation by Chia, Kelda et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Brain tumours repurpose endogenous neuron to microglia
signalling mechanisms to promote their own proliferation
Citation for published version:
Chia, K, Keatinge, M, Mazzolini, J & Sieger, D 2019, 'Brain tumours repurpose endogenous neuron to
microglia signalling mechanisms to promote their own proliferation', eLIFE, vol. 8.
https://doi.org/10.7554/eLife.46912
Digital Object Identifier (DOI):
10.7554/eLife.46912
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
eLIFE
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 11. May. 2020
 1 
Brain tumours repurpose endogenous neuron to microglia signalling 1 
mechanisms to promote their own proliferation. 2 
 3 
Kelda Chia 1, Marcus Keatinge 1, Julie Mazzolini 1 and Dirk Sieger 1* 4 
 5 
1 University of Edinburgh, Centre for Discovery Brain Sciences, 49 Little 6 
France Crescent, Edinburgh EH16 4SB, UK 7 
 8 
* Correspondence:  9 
Dirk Sieger  10 
Centre for Discovery Brain Sciences, 49 Little France Crescent, Edinburgh 11 
EH16 4SB, UK, Tel: +441312426161, mail: dirk.sieger@ed.ac.uk 12 
 13 
Abstract 14 
 15 
Previously we described direct cellular interactions between microglia and 16 
AKT1+ brain tumour cells in zebrafish (Chia et al., 2018). However, it was 17 
unclear how these interactions were initiated: it was also not clear if they had 18 
an impact on the growth of tumour cells. Here, we show that neoplastic cells 19 
hijack mechanisms that are usually employed to direct microglial processes 20 
towards highly active neurons and injuries in the brain. We show that AKT1+ 21 
cells possess dynamically regulated high intracellular Ca2+ levels. Using a 22 
combination of live imaging, genetic and pharmacological tools we show that 23 
these Ca2+ transients stimulate ATP mediated interactions with microglia. 24 
Interfering with Ca2+ levels, inhibiting ATP release and CRISPR mediated 25 
mutation of the p2ry12 locus abolishes these interactions. Finally, we show 26 
that reducing the number of microglial interactions significantly impairs the 27 
proliferation of neoplastic AKT1 cells. In conclusion, neoplastic cells 28 
repurpose the endogenous neuron to microglia signalling mechanism via 29 
P2ry12 activation to promote their own proliferation.  30 
 31 
 32 
 33 
 34 
 2 
Introduction 35 
 36 
Microglia and infiltrating macrophages are amongst the most abundant cell 37 
types in the microenvironment of brain tumours and have been shown to 38 
actively promote tumour growth (Hambardzumyan et al. 2015; Quail and 39 
Joyce 2017). A variety of mechanism contribute to this tumour promoting 40 
activity including modifications of the extracellular matrix, the induction of 41 
angiogenesis and the generation of an immunosuppressive environment 42 
(Markovic et al. 2005; Komohara et al. 2008; Wu et al. 2010; Zhai et al. 2010; 43 
Zhang et al. 2012; Ellert-Miklaszewska et al. 2013; Pyonteck et al. 2013; 44 
Wang et al. 2013; Hambardzumyan et al. 2015).  45 
Intriguingly, direct cellular interactions between microglia and brain tumour 46 
cells have been described (Bayerl et al. 2016; Hamilton et al. 2016; Resende 47 
et al. 2016; Ricard et al. 2016). These cellular interactions consist of different 48 
types of direct surface contacts between microglia and tumour cells, from 49 
microglia constantly extending processes towards tumour cells to microglia 50 
flattening their surfaces around tumour cells. Importantly, these interactions 51 
were long-lasting and did not appear to be anti-tumoural as phagocytic events 52 
were not observed. These observations have been consistently made in a 53 
variety of models of orthotopic transplantations of human and mouse glioma 54 
cells into mouse or zebrafish brains (Bayerl et al. 2016; Hamilton et al. 2016; 55 
Resende et al. 2016; Ricard et al. 2016). Furthermore, we have recently 56 
shown that these cellular interactions are initiated during the earliest stages of 57 
tumour growth as they can already be observed between microglia and pre-58 
neoplastic AKT1+ cells (Chia et al. 2018). However, the signals that initiate 59 
these cellular interactions and their functional impact on tumour cells have not 60 
been addressed so far.  61 
Several elegant studies have described cellular interactions between 62 
microglia and neurons under physiological conditions. Microglia have been 63 
observed to direct cellular processes towards neurons with increased 64 
intracellular Ca2+ levels (Li et al. 2012; Sieger et al. 2012; Eyo et al. 2014; 65 
2015). These interactions were regulated by ATP/ADP released from the 66 
neurons upon intracellular Ca2+ increase and sensed by the microglia via the 67 
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purinergic P2y12 receptor (Li et al. 2012; Sieger et al. 2012; Eyo et al. 2014; 68 
2015).  69 
Here, we hypothesized that mechanisms employed by healthy neurons to 70 
attract microglial processes are hijacked by neoplastic cells to stimulate 71 
interactions and that these interactions promote the growth of neoplastic cells. 72 
To address these questions, we made use of our recently published zebrafish 73 
brain tumour model to analyze interactions between microglia and neoplastic 74 
AKT1 overexpressing cells (Chia et al. 2018). We show that AKT1+ cells have 75 
significantly increased Ca2+ levels, which are dynamically regulated. 76 
Pharmacological inhibition of NMDA receptor signaling significantly decreased 77 
Ca2+ levels in AKT1+ cells and drastically reduced the number of microglial 78 
interactions with these cells. In line with these results, inhibition of ATP 79 
release and knock out of the p2y12 receptor abolished microglia interactions 80 
with AKT1+ cells, showing that Ca2+ mediated ATP signaling is required for 81 
these cellular contacts. Intriguingly, we showed that reducing these 82 
interactions had a direct functional impact on AKT1 cells and reduced their 83 
proliferative capacities.  84 
 85 
Results 86 
 87 
Microglia closely interact with pre-neoplastic AKT1 cells 88 
 89 
We and others have shown previously that microglia show direct cellular 90 
interactions with tumour cells and pre-neoplastic AKT1+ cells in the brain  91 
(Bayerl et al. 2016; Hamilton et al. 2016; Resende et al. 2016; Ricard et al. 92 
2016; Chia et al. 2018). However, the underlying mechanisms promoting 93 
these interactions have not been identified. Here we analysed these cellular 94 
contacts between microglia and pre-neoplastic AKT1+ cells in more detail. To 95 
induce AKT1 expression in neural cells we followed the previously published 96 
strategy by expressing AKT1 under the neural-specific beta tubulin (NBT) 97 
promoter using a dominant active version of the LexPR transcriptional 98 
activator system (ΔLexPR) (Chia et al. 2018). We co-injected an NBT:∆lexPR-99 
lexOP-pA driver plasmid together with a lexOP:AKT1-lexOP:tagRFP construct 100 
into mpeg1:EGFP transgenic zebrafish in which all macrophages including 101 
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microglia are labeled (Figure 1) (Ellett et al. 2011; Chia et al. 2018). Control 102 
fish were injected with a lexOP:tagRFP construct. In this model, cellular 103 
abnormalities and increased proliferation are detected in AKT1+ cells within 104 
the first week of development and solid tumours can be observed from 1 105 
month of age (Chia et al. 2018). As described previously, microglia were 106 
observed to cluster in areas of AKT1+ cells while their distribution appeared 107 
normal in fish injected with the lexOP:tagRFP control construct (Figure1A, B, 108 
Video 1 and 2). Furthermore, direct cellular interactions between microglia 109 
and AKT1+ cells seemed to be more frequent compared to interactions 110 
between microglia and RFP control cells. Thus, we decided to analyze these 111 
interactions in more detail and quantified these interactions. We counted the 112 
number of microglia in direct contact with AKT1+ or RFP control cells and 113 
normalized by the total number of microglia in the respective sample. 114 
Importantly, microglia showed a significantly increased number of direct 115 
interactions with AKT1+ cells compared to control cells (Figure 1C). As 116 
described before, different types of interactions were observed which ranged 117 
from microglia extending processes towards AKT1+ cells to microglia 118 
flattening and moving their cellular surface around AKT1+ cells (Figure 1D, E, 119 
Video 3 and 4). Furthermore, two or more microglial cells were frequently 120 
observed to interact with the same AKT1+ cell (Figure 1E, Video 4). 121 
Interestingly, overexpression of HRASV12 in neural cells as well as 122 
overexpression of AKT1 and HRASV12 under control of the zic4 enhancer 123 
stimulated similar microglial responses (Figure 1-figure supplement 1). Thus, 124 
cells in the brain undergoing oncogenic transformation via AKT1 and 125 
HRASV12, seem to possess signals stimulating these long-lasting 126 
interactions. 127 
 128 
AKT1 positive cells show increased intracellular Ca2+ levels 129 
 130 
Increased Ca2+ levels in neurons have been shown to mediate ATP release, 131 
which stimulates microglia processes towards these neurons (Li et al. 2012; 132 
Sieger et al. 2012; Eyo et al. 2014; 2015). Thus, we hypothesized that AKT1+ 133 
cells would exhibit increased intracellular Ca2+ levels compared to control 134 
cells. To prove this hypothesis, we made use of transgenic b-actin:GCaMP6f 135 
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zebrafish which ubiquitously express the calcium sensor GCamP6f. We 136 
overexpressed AKT1 in b-actin:GCaMP6f larvae and imaged the larval brains. 137 
We then quantified GCaMP6F fluorescence in AKT1+ cells compared to 138 
control cells by measuring the mean relative fluorescence intensity change 139 
(∆F/F0) (Baraban et al. 2017). Indeed, these quantifications showed a steady 140 
increase of Ca2+ levels in AKT1+ cells compared to control cells over time 141 
(Figure 2A-C). Ca2+ levels were significantly increased in AKT1+ cells from 4 142 
dpf onwards and showed a drastic increase at 7 dpf (Figure 2C). When 143 
normalised against control ∆F/F0 values, the significance was further 144 
pronounced with percentage fold change of Ca2+ levels of AKT1 cells 145 
increasing from 189.7 ± 70.6% at 4 dpf, to 204.8 ± 102.1% (5 dpf) and 250.2 ± 146 
67.1% (6 dpf) respectively, to over 1615.3 ± 271.4% by 7 dpf. We speculate 147 
that increased Ca2+ levels are part of the process of oncogenic transformation 148 
as we observed similar increases upon overexpression of HRASV12 in neural 149 
cells (not shown). 150 
To test if these increased Ca2+ levels were dynamic over time, we recorded 151 
individual brains using spinning disk confocal microscopy with a time 152 
resolution of 1 frame/sec. For the analysis, the ∆F/F0 of any selected cell-of-153 
interest was measured along the time-course and plotted as a function of 154 
∆F/F0 against time. Interestingly, these recordings showed further differences 155 
between control cells and AKT1+ cells. In control RFP cells, calcium activity 156 
was observed to be relatively static over time (n = 35 larvae analysed; Figure 157 
2D, Video 5). With the exception of some spontaneous background firing, 158 
there were no spikes or obvious changes in calcium firing pattern recorded in 159 
control neural cells throughout the duration of image acquisition (Figure 2D, 160 
Video 5). Interestingly, AKT1 expressing cells were observed to temporally 161 
regulate calcium activity. Through the course of acquisition, ~31 % of AKT1 162 
positive cells were observed to strongly up- and down-regulate Ca2+ levels 163 
(∆F/F0 increase > 0.05) repeatedly, thus creating a firing pattern (n = 35 larvae 164 
analysed; Figure 2E, Video 6). We did not detect these patterns in any of the 165 
analysed control RFP cells (n = 35 larvae analysed). While these dynamic 166 
changes in calcium firing were specific to individual AKT1 positive cells, they 167 
were more frequently observed in cells within close vicinity to other AKT1 168 
expressing cells. Thus, AKT1 induced pre-neoplastic alterations result in 169 
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increased Ca2+ levels, which appear to be dynamically regulated over time. To 170 
test if microglia directly respond to increases in Ca2+ levels we overexpressed 171 
AKT1 in b-actin:GCaMP6f/mpeg1:EGFP double transgenic larvae. This 172 
combination has the caveat that microglia and Ca2+ signals are imaged in the 173 
same channel. Thus, imaging settings had to be carefully adjusted to avoid 174 
massive overexposure of the microglia while still capturing the GCaMP6f 175 
signals. Importantly, we detected microglia directly responding to AKT1+ cells 176 
with increased Ca2+ levels. We observed prolonged cellular contacts between 177 
microglia and AKT1+ cells with increased Ca2+ levels (Figure 3A-D, arrows) 178 
as well as microglia sending processes towards AKT1+ cells that increased 179 
their Ca2+ levels during the time of the acquisition (Figure 3A-H, arrowheads). 180 
These results suggest, that increased Ca2+ levels in AKT1+ cells stimulate 181 
microglial contacts.  182 
 183 
Ca2+-ATP-P2ry12 signaling is required for cellular contacts between microglia 184 
and AKT1+ cells 185 
 186 
To test if increased Ca2+ levels correlate with increased microglial interactions 187 
we took pharmacological and genetic approaches. First, we incubated larvae 188 
with a mixture of MK801 and MK5 to inhibit NMDA receptor mediated Ca2+ 189 
entry into cells (Sieger et al. 2012). Inhibition of NMDA receptor signaling led 190 
to a significant reduction of Ca2+ levels in AKT1+ cells compared to the 191 
AKT1+ cells in untreated larvae (Figure 4A). In line with the reduction of Ca2+ 192 
levels we detected a significant reduction in the number of microglial 193 
interactions with AKT1+ cells (Figure 4B). Thus, increased Ca2+ levels in 194 
AKT1+ cells are required to attract microglial processes.  195 
Attraction of microglial processes to neurons with increased Ca2+ levels have 196 
been shown to be regulated via the release of ATP/ADP, which is sensed by 197 
the P2y12 receptor expressed on microglia (Li et al. 2012; Sieger et al. 2012; 198 
Eyo et al. 2014; 2015). Consequently, inhibiting ATP and P2ry12 signaling 199 
abolishes microglial responses to cellular increases in Ca2+ levels. To test if 200 
microglial responses to AKT1+ cells were mediated via the same mechanism 201 
we reduced ATP release by treating larvae with CBX to block pannexin 202 
channels as described before (Chekeni et al. 2010; Sieger et al. 2012). 203 
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Indeed, inhibiting pannexin channels led to a significant reduction of cellular 204 
interactions between microglial cells and AKT1+ cells (Figure 4C). Finally, we 205 
decided to inhibit P2ry12 signaling using a genetic approach. Importantly, 206 
p2ry12 expression is highly specific to microglia in the brain and p2ry12 is 207 
considered to be a microglia signature gene (Crotti and Ransohoff 2016). 208 
Thus, we performed CRISPR manipulation with a p2ry12 gene-specific guide 209 
RNA (gRNA). Acute injection of the p2ry12 gRNA efficiently mutated the 210 
p2ry12 gene as shown by restriction fragment length polymorphism (RFLP) 211 
analysis, while injection of a control gRNA did not cause mutation of the 212 
p2ry12 gene (Figure 4-figure supplement 1A, B). RFLP analysis demonstrated 213 
the p2ry12 gRNA had a mutation rate approaching 100% (Figure 4-figure 214 
supplement 1A, B). To further confirm efficiency on protein level we injected 215 
gRNA into double transgenic p2ry12-GFP/mpeg1:mCherry zebrafish in which 216 
microglia (and all other macrophages) are labeled with mCherry and microglia 217 
are additionally labeled by the P2ry12-GFP fusion protein (Figure 4-figure 218 
supplement 1C). Importantly, the p2ry12-GFP zebrafish were created by BAC 219 
mediated recombination of a GFP fusion into the genomic p2ry12 locus 220 
(Sieger et al. 2012), thus allowing assessment of endogenous P2ry12 221 
expression. Injection of a control gRNA into these double transgenic fish did 222 
neither alter mCherry nor P2ry12-GFP expression (Figure 4-figure 223 
supplement 1C). Injection of p2ry12 gRNA into these fish did not, as 224 
expected, impact on mCherry expression on microglia (Figure 4-figure 225 
supplement 1C). However, P2ry12-GFP expression was clearly abolished on 226 
the microglia, revealing complete knockout of the P2ry12 protein (Figure 4-227 
figure supplement 1C).  Thus, the gRNA injected produced an effective 228 
mosaic null, herein referred to as p2yr12 crispant. We then quantified 229 
microglial interactions with AKT1+ cells in p2yr12 wildtype brains (no gRNA + 230 
control gRNA) and p2ry12 crispant brains. Importantly, in the p2ry12 crispant 231 
background microglia interactions with AKT1+ cells were significantly reduced 232 
(Figure 4D). Quantifications revealed that while on average ~40% of microglia 233 
interacted with AKT1+ cells in p2ry12 wt brains, only ~21% of microglia 234 
showed interactions with AKT1+ cells in the p2ry12 crispant background 235 
(Figure 4D).  236 
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In conclusion, these experiments show that P2ry12 signaling in microglia is 237 
required to mediate cellular interactions with AKT1+ cells.  238 
 239 
Microglial interactions promote proliferation of AKT1+ cells 240 
 241 
We have shown that microglial interactions with AKT1+ cells were abolished 242 
in p2ry12 crispant brains. To test if the reduced number of interactions had a 243 
direct functional impact on the growth of AKT1+ cells, we measured 244 
proliferation rates of AKT1+ cells in p2ry12 wildtype brains (no gRNA + control 245 
gRNA) and p2ry12 crispant brains. As described previously, AKT1+ cells 246 
showed significantly increased proliferation rates compared to control cells in 247 
wt brains (Figure 5B) (Chia et al. 2018). In p2ry12 crispant brains no 248 
differences were detected in the proliferation rates of control RFP cells 249 
compared to p2yr12 wildtype brains (Figure 5B). However, we found an 250 
almost 50% drop in the proliferation rate of AKT1+ cells in p2ry12 crispant 251 
brains compared to p2ry12 wildtype brains (Figure 5B). As numbers of 252 
microglia were similar in p2ry12 crispant brains and p2yr12 wildtype brains 253 
(Figure 5A), we conclude that the reduced number of interactions in p2ry12 254 
crispant brains was the reason for the decrease in proliferation of AKT1 cells. 255 
Thus, microglia interactions directly promote proliferation of pre-neoplastic 256 
AKT1 cells. 257 
 258 
Discussion 259 
 260 
A number of elegant studies have described the mechanism how microglial 261 
processes are attracted towards highly active neurons and injuries within the 262 
brain (Davalos et al. 2005; Li et al. 2012; Sieger et al. 2012; Eyo et al. 2014; 263 
2015). Here, we showed that pre-neoplastic cells hijack the same mechanism 264 
to attract microglial processes. We showed that increased Ca2+ levels in 265 
AKT1+ cells, the release of ATP from these cells and P2ry12 signaling on 266 
microglia are required to stimulate microglial interactions with AKT1+ cells. 267 
Intriguingly, we showed that these interactions promote an increase in 268 
proliferation of the pre-neoplastic cells. Thus, we have identified a new 269 
process that contributes to the pro-tumoural activities of microglia.  270 
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A variety of mechanisms have been described how macrophages and 271 
microglia promote the growth of tumours. These mechanisms range from the 272 
release of cytokines and chemokines to modifications of the extracellular 273 
matrix (reviewed in (Hambardzumyan et al. 2015)). Here, we identify direct 274 
cellular interactions between microglia and pre-neoplastic cells as a cause of 275 
increased proliferation. Interestingly, cellular interactions between 276 
macrophages and tumour cells have been described recently in other tumour 277 
contexts. Roh-Johnson et al. showed direct cellular contacts between 278 
macrophages and melanoma cells (Roh-Johnson et al. 2017). These cellular 279 
contacts resulted in the transfer of cytoplasm from macrophages to melanoma 280 
cells which led to an increased dissemination of the melanoma cells (Roh-281 
Johnson et al. 2017). Furthermore, macrophage contacts with breast cancer 282 
cells have been shown to induce RhoA GTPase signaling within the cancer 283 
cells and to trigger their intravasation (Roh-Johnson et al. 2014). 284 
Nevertheless, several open questions remain to be answered here. What is 285 
the content within the transferred cytoplasm that leads to increased 286 
invasiveness of melanoma cells? How do macrophages upregulate RhoA 287 
GTPase activity within breast cancer cells? How do microglia induce 288 
proliferation of pre-neoplastic cells? We hypothesize that microglial processes 289 
alter the Ca2+ levels within the pre-neoplastic cells which might trigger 290 
changes in their proliferative capacities. This is in line with previous studies 291 
showing a Ca2+-dependent increase in transcription factors which are crucial 292 
for cellular division, proliferation, as well as cancer cell survival (reviewed by 293 
(Roderick and Cook 2008)). Future studies will reveal if the microglia 294 
mediated increase in proliferation is mediated via ligand-receptor interactions 295 
or via a transfer of cytoplasm as shown for macrophages and melanoma cells 296 
previously. 297 
AKT1+ cells did not only show increased Ca2+ levels but also showed a 298 
dynamic regulation of Ca2+ levels. Interestingly, cells that were within close 299 
vicinity to other AKT1 expressing cells showed an increased frequency of 300 
fluctuations in their Ca2+ levels. Thus, it’s tempting to speculate that these 301 
cells communicate via Ca2+ transients. Interestingly, in an elegant in vivo 302 
study, astrocytoma cells have been shown to form a functional network which 303 
is connected via tumour microtubes (TMs) (Osswald et al. 2015). Astrocytoma 304 
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cells within the network showed survival benefits and resistance against 305 
radiotherapy (Osswald et al. 2015). Importantly, dynamic Ca2+ transients have 306 
been observed within this network and a role for the network in brain invasion 307 
and proliferation has been described. Future studies will address if the Ca2+ 308 
transients within AKT1+ cells shown here resemble early signs of network 309 
formation. As we observed microglia to directly interact with these AKT1+ 310 
cells and their processes, we speculate that microglia contribute to the 311 
establishment of a functional network between tumour cells by promoting the 312 
outgrowth of TMs. This might be mediated by factors that have been identified 313 
before and shown to be involved in developmental processes. Microglia have 314 
been shown for example to promote neuronal survival and axonal growth by 315 
providing insulin-like growth factor 1 (IGF-1) (Ueno et al. 2013). Thus, it will be 316 
interesting to analyse the role of IGF-1 and other developmental factors in the 317 
outgrowth of TMs.  318 
  319 
Future studies will reveal if the mechanism identified here is employed by the 320 
large variety of brain tumours and if promotion of proliferation by microglial 321 
processes is a general phenomenon within brain tumours. As expression of 322 
the P2y12 receptor, which mediates these interactions, is specific for 323 
microglia in the brain, pharmacological inhibition of the receptor might offer 324 
new routes for therapy to reduce proliferation of the tumour cells.  325 
 326 
Materials and Methods 327 
 328 
Key resources table 329 
 330 
Reagent 
type 
(species) or 
resource 
Designation 
Source 
or 
reference 
Identifiers 
Additional 
information 
antibody 
anti-4C4 (mouse 
monoclonal) 
Becker 
Lab, 
University 
of 
Edinburgh 
  (1:50) 
antibody 
anti-PCNA 
(rabbit 
abcam 
abcam: ab18197; 
RRID:AB_2160346 
(1:300) 
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polyclonal) 
antibody 
Alexa 488- or 
647 secondaries 
Life 
Technolo
gies 
Life Technologies: A11001 
(RRID:AB_138404), 
A21235 
(RRID:AB_141693), 
A11008 
(RRID:AB_143165), 
A21244 (RRID:AB_141663) 
(1:200) 
chemical 
compound, 
drug 
Carbenoxolone 
(CBX) 
Sigma-
Aldrich 
Sigma-Aldrich: C 4790 
50 µM, 1% 
DMSO 
chemical 
compound, 
drug 
MK-801 
Sigma-
Aldrich 
Sigma-Aldrich: M107 100 µM 
chemical 
compound, 
drug 
AP5 
Sigma-
Aldrich 
Sigma-Aldrich: A5282 10 µM 
gene (Homo 
sapiens) AKT1 NA ENSG00000142208   
gene (Homo 
sapiens) HRASV12 NA ENSG00000174775   
recombinant 
DNA reagent 
lexOP-AKT1-
RFP (plasmid) 
PMID: 
29465400 lexOP:AKT1-lexOP:tagRFP 
Gateway 
vector: 
pDEST 
recombinant 
DNA reagent 
lexOP-
HRASV12-RFP 
(plasmid) this paper 
lexOP:HRASV12-
lexOP:tagRFP 
Gateway 
vector: 
pDEST 
recombinant 
DNA reagent 
UAS-AKT1-BFP 
(plasmid) this paper UAS:AKT1:UAS:BFP 
Gateway 
vector: 
pDEST 
recombinant 
DNA reagent 
UAS-eGFP-
HRASV12 
(plasmid) 
PMID: 
27935819 UAS:EGFP-HRASV12 
Gateway 
vector: 
pDEST 
recombinant 
DNA reagent 
lexOP-tagRFP 
(plasmid) 
PMID: 
29465400 lexOP:tagRFP-pA 
Gateway 
vector: 
pDEST 
strain, strain 
background 
(D rerio) zic:Gal4 
PMID: 
19628697 
Et(zic4:GAL4TA4,UAS:mCh
erry)hmz5 , ZDB-
ETCONSTRCT-110214-1   
strain, strain 
background 
(D rerio) 
b-
actin:GCaMP6f 
PMID: 
31076485  Tg(b-actin:GCaMP6f)    
strain, strain 
background 
(D rerio) mpeg1:EGFP 
PMID: 
21084707 
Tg(mpeg1:EGFP)gl22 , 
RRID:ZIRC_ZL9940   
strain, strain 
background 
(D rerio) mpeg1:mCherry 
PMID: 
21084707 
Tg(mpeg1:mCherry)gl23 , 
RRID:ZIRC_ZL9939   
strain, strain 
background 
(D rerio) 
NBT:∆lexPR-
lexOP-pA 
PMID: 
29465400 
Tg(XIa.Tubb:LEXPR)Ed7 , 
ZDB-ALT-180108-4   
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strain, strain 
background 
(D rerio) 
p2ry12:p2ry12-
GFP 
PMID: 
22632801 
TgBAC(p2ry12:p2ry12-
GFP) , RRID:ZFIN_ZDB-
ALT-121109-2   
software, 
algorithm Imaris 8.0.2 Bitplane RRID:SCR_007370   
chemical 
compound, 
drug TracrRNA Merck Merck: TRACRRNA05N   
chemical 
compound, 
drug guide RNA Merck Merck: custom made   
peptide, 
recombinant 
protein Cas9 nuclease NEB NEB: M0386M   
 331 
Zebrafish maintenance 332 
 333 
Zebrafish were housed in a purpose-built zebrafish facility, in the Queen’s 334 
Medical Research Institute, maintained by the University of Edinburgh 335 
Bioresearch and Veterinary Services. All zebrafish larvae were kept at 28°C 336 
on a 14 hours light/10 hours dark photoperiod. Embryos were obtained by 337 
natural spawning from adult Tg(mpeg1:EGFP)gl22 referred to as 338 
mpeg1:EGFP (Ellett et al. 2011), Tg(mpeg1:mCherry) referred to as 339 
mpeg1:mCherry, wildtype (AB), TgBAC(p2ry12:p2ry12-GFP)hdb3 referred to 340 
as p2ry12:p2ry12-GFP (Sieger et al. 2012),  341 
Et(zic4:GAL4TA4,UAS:mCherry)hmz5 referred to as zic4:Gal4 (Distel et al., 342 
2009) and Tg(b-actin:GCaMP6f) referred to as b-actin:GCaMP6f (Herzog et 343 
al., 2019) and Tg(XIa.Tubb:LEXPR)Ed7 referred to as NBT:∆lexPR-lexOP-pA 344 
(NBT:∆lexPR) (Chia et al. 2018). Embryos were raised at 28.5ºC in embryo 345 
medium (E3) and treated with 200 μM 1-phenyl 2-thiourea (PTU) (Sigma) 346 
from the end of the first day of development for the duration of the experiment 347 
to inhibit pigmentation. Animal experimentation was approved by the ethical 348 
review committee of the University of Edinburgh and the Home Office, in 349 
accordance with the Animal (Scientific Procedures) Act 1986. 350 
 351 
DNA injections to induce oncogene expression and cellular transformation 352 
 353 
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To achieve transient expression of AKT1 and HRASV12, zebrafish embryos 354 
were injected at the 1 cell stage as previously described (Chia et al. 2018). 355 
Approximately 2 nL of plasmid DNA (30 ng/µL) containing Tol2 capped mRNA 356 
(20 ng/µL) and 0.2% phenol red were injected into NBT:∆lexPR-lexOP-pA 357 
fish. To obtain AKT1 or HRASV12 expression in other transgenic 358 
backgrounds, a Tol2-pDEST-NBT:∆lexPR-lexOP-pA (20 ng/µL) plasmid was 359 
co-injected with a Tol2-pDEST-lexOP:AKT1-lexOP:tagRFP (30 ng/µL) 360 
plasmid or with a Tol2-pDEST-lexOP:HRASV12-lexOP:tagRFP (30 ng/µL) 361 
plasmid. To obtain control RFP expression Tol2-pDEST-lexOP:tagRFP-pA 362 
was injected. To obtain AKT1 expression under control of the zic4 enhancer 363 
the zic:Gal4 line was crossed with mpeg1:EGFP and injected with a Tol2-364 
pDEST-UAS:AKT1-UAS:BFP (30 ng/µL) plasmid. To obtain HRASV12 365 
expression under control of the zic4 enhancer the zic:Gal4 line was used and 366 
injected with a Tol2-pDEST-UAS:eGFP-HRASV12 (30 ng/µL) plasmid. Larvae 367 
were screened at 2 days post-fertilization (dpf) for positive transgene 368 
expression and selected for further experiments.  369 
 370 
CRISPR/Cas9 mediated p2ry12 mutation 371 
 372 
Somatic mosaic p2ry12 mutations were generated via a CRISPR/Cas9 373 
approach as described before (Tsarouchas et al. 2018). The CrRNA 374 
for p2yr12 (target sequence: 5′-CCAGTTCTACTACCTGCCCACGG-3′, 375 
targeting a bsl1 restriction enzyme site), the control CrRNA (target 376 
sequence: 5′-CCTCTTACCTCAGTTACAATTTATA-3′) and the TracrRNA 377 
were ordered from Merck KGaA (Germany, Darmstadt). The injection mix 378 
included 1 μl TracrRNA 250 ng/μl, 1 μl CrRNA 250ng/ul, 1 μl Cas9 protein 1 379 
μM (NEB). To knock out p2ry12 and obtain AKT1 expression in the same 380 
larva, a Tol2-pDEST-lexOP:AKT1-lexOP:tagRFP was co-injected with the 381 
CRISPR/Cas9 injection mix of Cas9 protein, TracrRNA, and p2ry12 CrRNA or 382 
control CrRNA. To obtain experimental controls, the Tol2-pDEST-383 
lexOP:tagRFP-pA was co-injected. To confirm p2yr12 locus had been 384 
mutated restriction fragment length polymorphism (RFLP) analysis was 385 
performed using the bsl1 enzyme (NEB). The PCR primer pair used was: 386 
Forward primer: 5’- AGCTCAGCTTCTCCAACAGC-3’; Reverse primer: 387 
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5’GCTACATTGGCAT CGGATAA-3’. PCR products were digested with the 388 
bsl1 restriction enzyme (55˚C for 1 h). 389 
 390 
Whole mount immunohistochemistry, image acquisition and live imaging 391 
 392 
Whole mount immunostaining of samples was performed as previously 393 
describe (Chia et al. 2018). Briefly, larvae were fixed in 4% PFA/1% DMSO at 394 
room temperature for 2 h, followed by a number of washes in PBStx (0.2% 395 
Triton X-100 in 0.01 M PBS), and blocked in 1% blocking buffer (1% normal 396 
goat serum, 1% DMSO, 1% BSA, 0.7% Triton X-100 in 0.01 M PBS) for 2 h 397 
prior to incubation with primary antibodies overnight at 4ºC. Primary 398 
antibodies used were rabbit anti-PCNA (1:300) (ab18197, abcam) and mouse 399 
anti-4C4 (1:50). A series of washes in PBStx was carried out before samples 400 
were subsequently incubated in conjugated secondary antibodies (goat anti-401 
mouse Alexa Fluor 488 [1:200]; goat anti-mouse Alexa Fluor 647 [1:200]; goat 402 
anti-rabbit Alexa Fluor 488 [1:200]; goat anti-rabbit Alexa Fluor 647 [1:200]) 403 
(Life Technologies) overnight at 4ºC to reveal primary antibody localizations. 404 
Samples were washed following secondary antibody incubation and kept in 405 
70% glycerol at 4ºC until final mounting in 1.5% low melting point agarose 406 
(Life Technologies) in E3 for image acquisition.  407 
Whole brain immuno-fluorescent images were acquired using confocal laser 408 
scanning microscopy (Zeiss LSM710 and LSM780; 20x/0.8 objective; 2.30 µm 409 
intervals; 488-, 543-, and 633-nm laser lines).  410 
Live imaging of zebrafish larvae was performed as previously described (Chia 411 
et al. 2018); samples were anaesthetized with 0.2 mg/mL Tricaine (MS222, 412 
Sigma) and mounted dorsal side down in 1.5% low melting point agarose (Life 413 
Technologies), in glass-bottom dishes (MatTek) filled with E3 containing 0.2 414 
mg/mL Tricaine. Single time-point live images were acquired through confocal 415 
imaging (Zeiss LSM710; 20x/0.8 objective; 2.30 µm intervals; 488-, and 543-416 
nm laser lines). To investigate GCamp6f fluorescence and direct interactions 417 
between oncogene-expressing cells and microglia, time-lapse imaging was 418 
performed on a spinning disk confocal microscope (Andor iQ3; 20x/0.75 & 419 
W40x/1.15 objectives; 1.5-2 µm z-intervals; 488- and 543-nm laser lines). All 420 
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time-lapse acquisitions were carried out in temperature-controlled climate 421 
chambers set to 28ºC for 10-18 h. 422 
 423 
Image analysis and quantifications 424 
 425 
Analyses of all images were conducted using Imaris (Bitplane, Zurich, 426 
Switzerland). For the quantification of 4C4+ cells, only cells within the brain 427 
(telencephalon, tectum, and cerebellum) were counted for each sample using 428 
the “Spots” function tool in Imaris 8.0.2.  429 
To quantify proliferation rates, the number of PCNA+/RFP+ cells were counted 430 
in relation to the total number of RFP+ cells and the averaged value 431 
expressed as measure of percentage proliferation (described before in (Chia 432 
et al. 2018)).  433 
To quantify the relative Ca2+ (GCaMP6f) intensity levels used for analyses, 434 
the mean relative fluorescence intensity change (∆F/F0) was determined. The 435 
mean intensity of the GCaMP6f channel from the image was used to acquire 436 
the Ca2+ baseline fluorescence intensity (F0). To determine the fluorescence 437 
intensity change (∆F), the “Surfaces” function in Imaris 8.0.2 was utilized to 438 
identify and segment all RFP+ neural cells. The mean Ca2+ (GCaMP6f) 439 
intensity levels were recorded for individual cells. The final ∆F used was 440 
determined as the average mean intensity of the GCaMP6f fluorescence from 441 
all the segmented cells-of-interest.  442 
Changes in Ca2+ levels over time were analysed as previously described 443 
(Baraban et al. 2017). Briefly, to quantify changes in calcium activity over time 444 
in individual cells, regions of interest (ROI) were manually applied to identify 445 
the cell-of-interest. A separate ROI was applied to an area with no GCaMP6f 446 
expression to represent background fluorescence. To determine the final 447 
∆F/F0, the following formula was applied: ∆F/F0 = (F t−F0)/(F0−Fbackground); 448 
where Ft is the fluorescent intensity in the ROI at time-point ‘t’, F0 represents 449 
the average fluorescent intensity of the first 10 frames of the ROI, and 450 
Fbackground represents the fluorescent intensity of the background ROI at time-451 
point ‘t’. 452 
To observe microglia interactions with RFP control cells and AKT1 positive 453 
cells, control RFP or AKT1 expression was induced in the mpeg1:EGFP 454 
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transgenic zebrafish line. To determine microglial-neural cell interactions, the 455 
number of mpeg+ microglia cells in direct contact with control RFP cells or 456 
AKT1 cells were counted. To normalise for the difference in microglial 457 
numbers across samples this number was divided by the total number of 458 
mpeg+ microglial cells of the respective sample. Quantifications were plotted 459 
as the percentage of microglial cells in contact with RFP or AKT1 cells.   460 
 461 
Pharmacological treatments 462 
 463 
To inhibit ATP release larvae were treated with CBX 50 µM/1% DMSO 464 
(Sigma) from 3 dpf until 5 dpf. To obtain experimental controls, age-matched 465 
samples were incubated in 1% DMSO. CBX treated larvae appeared inactive 466 
compared to controls and showed a reduced escape reaction upon 467 
mechanical stimulation. Inhibition of NMDA receptor signaling was achieved 468 
by treating larvae with a mixture of MK801 (100 µM) and AP5 (10 µM) (both 469 
Sigma) at 7 dpf for 5 hours.  470 
Statistical analysis 471 
 472 
All experiments were performed in at least 2 replicates with n indicating the 473 
total number of larvae. All measured data were analyzed (StatPlus, 474 
AnalystSoft Inc.). Two-tailed Student’s t-tests were performed between two 475 
experimental groups and one-way ANOVA with Bonferroni’s post-hoc tests or 476 
two-way ANOVA were performed for comparisons between multiple 477 
experimental groups. Statistical values of p < 0.05 were considered to be 478 
significant. All graphs were plotted in Prism 6.1 (GraphPad Software) and 479 
values presented as population means (± SEM). 480 
 481 
 482 
Figure Legends 483 
 484 
Figure 1. Microglia show increased interactions with AKT1 expressing 485 
cells compared to control cells. In vivo time-lapse imaging was performed 486 
using the mpeg1:EGFP transgenic line to observe microglia behaviour 487 
towards control cells and AKT1 cells. (A) In controls, microglia were observed 488 
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to behave physiologically. Cells adopted the typical ramified morphology 489 
constantly sending out branched processes to survey the microenvironment 490 
[See also Video 1]. (B) Following AKT1 overexpression, microglia were 491 
observed to directly interact with AKT1+ cells [See also Video 2]. (C) 492 
Quantification of the percentage of microglia interacting with control and AKT1 493 
positive cells [Control: 16.86 ± 1.33%, n = 20; AKT1: 41.79 ± 2.65%, n = 21]. 494 
Specific microglia interactions with AKT1+ cells include (D) the wrapping of 495 
cell bodies around the oncogenic cells [See also Video 3], as well as (E) two 496 
microglial cells making direct contacts with AKT1+ via their extended 497 
processes (white arrows) [See also Video 4]. Representative images at 5 dpf 498 
are shown. Images were captured using an Andor spinning disk confocal 499 
microscope with a 20x/0.75 objective.  500 
Image acquisition was carried out over a duration of 180 min (3 hr). Scale 501 
bars represent 30 µm. Error bars represent mean ± SEM.  502 
 503 
Figure 1-figure supplement 1. Microglial responses to oncogenic cells. 504 
Microglia were seen to directly interact with NBT cells and zic4 cells 505 
undergoing oncogenic transformation caused by AKT1 and HRAV12. 506 
Microglia were visualised using the mpeg1:EGFP line in NBT-HRASV12 and 507 
zic4-AKT1 larvae and visualised using the 4C4 antibody in the zic4-HRASV12 508 
larvae. Representative images at 6 dpf are shown. Images were captured 509 
using an Andor spinning disk confocal microscope with a 20x/0.75 objective 510 
and a Zeiss LSM 710 confocal microscope with a 20x/0.8 objective. Scale 511 
bars represent 40 µm for NBT HRASV12 larvae and 50 µm for zic4 larvae.  512 
 513 
Figure 2. AKT1 expressing cells have increased levels of intracellular 514 
Ca2+. The β-actin:GCaMP6f transgenic line was used to monitor and measure 515 
in vivo calcium (Ca2+) levels in control and AKT1+ cells. (A-A”) Control neural 516 
cells showed a low, homogenous basal level of intracellular Ca2+. (B-B”) 517 
AKT1+ cells showed cell specific increase in intracellular Ca2+ levels (white 518 
arrowheads). (C) Quantification of the mean relative fluorescence intensity 519 
change (∆F/F0) of control and AKT1+ cells at 4 dpf, 5 dpf, 6 dpf, and 7 dpf. 520 
Significant differences were observed between control and AKT1 expressing 521 
larvae at all 4 time points. [Control – 4 dpf: 0.0240 ± 0.0078, n = 22; 5 dpf: 522 
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0.0296 ± 0.0097, n = 19; 6 dpf: 0.0253 ± 0.0098, n = 25; 7 dpf: 0.00815 ± 523 
0.0059, n = 25]. [AKT1 – 4 dpf: 0.0455 ± 0.0055, n = 29; 5 dpf: 0.0606 ± 524 
0.0099, n = 22; 6 dpf: 0.0633 ± 0.0066, n = 20; 7 dpf: 0.132 ± 0.016, n = 32]. 525 
Representative images of larvae at 8 dpf are shown.  526 
(D) + (E) To monitor changes in Ca2+ levels over time, samples were imaged 527 
over 5 minutes (300 s) with a capture rate of 1 frame/sec. The data has been 528 
normalized and represented as a function of ∆F/F0 plotted against time. (D) 529 
Calcium activity in control cells showed no changes over time (n = 35 larvae 530 
analysed) [See also Video 5]. (E) AKT1 expressing cells were found to 531 
temporally regulate calcium activity, through up- and down-regulation of Ca2+ 532 
levels (n =35 larvae analysed) [See also Video 6]. Images were captured 533 
using an Andor spinning disk confocal microscope with a 20x/0.75 objective. 534 
Scale bars represent 20 µm. Error bars represent mean ± SEM.  535 
 536 
Figure 3. Microglia directly respond to increased levels of intracellular 537 
Ca2+ in AKT1+ cells. 538 
Microglia were observed to display various different responses towards AKT1 539 
positive cells with upregulated Ca2+ levels. One type of interaction was the 540 
prolonged cell-to-cell contact between the microglial cell and the AKT1 541 
expressing cell (A-D, arrows). In addition, microglia were observed to extend 542 
processes towards AKT1 cells with increased calcium activities (A-H, 543 
arrowheads). Representative images at 5 dpf are shown. Images were 544 
captured using an Andor spinning disk confocal microscope with a 20x/0.75 545 
objective. Scale bars represent 20 μm.  546 
 547 
Figure 4. Ca2+-ATP-P2ry12 signalling stimulates microglial interactions 548 
with AKT1 cells. The β-actin:GCaMP6f transgenic line was used to monitor 549 
and measure in vivo calcium (Ca2+) levels in control and AKT1 expressing 550 
cells. The mpeg1:EGFP transgenic line was used to quantify microglial 551 
interactions with control and AKT1 cells. (A) Treating larvae with MK801 and 552 
MK5 to inhibit NMDA receptor signaling led to a significant reduction of Ca2+ 553 
levels in treated AKT1 cells compared to untreated AKT1 cells. Quantification 554 
of the mean relative fluorescence intensity (∆F/F0) of Ca
2+ levels in control 555 
and in AKT1 expressing cells is shown [control (WT): 0.0081 ± 0.006, n = 25; 556 
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AKT1 (WT): 0.1316 ± 0.016, n = 32; control (MK801 + MK5): 0.0085 ± 0.004, 557 
n = 16; AKT1 (MK801 + MK5): 0.0211 ± 0.007, n = 16]. (B) The percentage of 558 
microglial cells interacting with AKT1 cells was significantly reduced in larvae 559 
treated with MK801 and MK5 compared to untreated larvae. [Control (WT): 560 
18.89 ± 1.32, n = 10; AKT1 (WT): 43.75 ± 3.95, n = 10; Control (MK801 + 561 
MK5): 17.59 ± 1.89, n = 21; AKT1 (MK801 + MK5): 24.94 ± 1.36, n = 20].  (C) 562 
The percentage of microglial cells interacting with AKT1 cells was significantly 563 
reduced in larvae treated with CBX compared to untreated larvae [Control 564 
(DMSO): 17.11 ± 3.02%, n = 10; AKT1 (DMSO): 41.92 ± 2.09%, n = 10; 565 
Control (CBX): 12.42 ± 1.42%, n = 13; AKT1 (CBX): 26.99 ± 2.19%, n = 9].(D) 566 
The percentage of microglial cells interacting with AKT1 cells was significantly 567 
reduced in p2ry12 crispant larvae compared to WT larvae [Control (WT): 568 
14.82 ± 2.19%, n = 10; AKT1  (WT): 40.01 ± 3.66%, n = 11; Control (ctrl-569 
gRNA): 17.38 ± 3.09%, n = 6; AKT1 (ctrl-gRNA): 44.42 ± 1.46%, n = 7; 570 
Control (p2ry12-/-): 12.33 ± 2.97%, n = 7; AKT1 (p2ry12-/-): 20.88 ± 2.29%, n = 571 
10]. 572 
 573 
Figure 4-figure supplement 1. CRISPR/Cas9 mediated mutation of the 574 
p2ry12 gene. Acute mutation of the p2ry12 gene was mediated through the 575 
injection of Cas9 and the p2ry12 guide RNA into one cell stage embryos. (A)  576 
Restriction fragment length polymorphism (RFLP) analysis was carried out on 577 
single embryos to confirm the efficiency of the guide RNA in mutating the 578 
p2ry12 gene. Injection of a control guide did not mutate the p2ry12 locus 579 
(lower picture).  (B) Injection of  Cas9 and the p2ry12 guide RNA  into 580 
experimental controls (RFP only) and AKT1 induced samples caused efficient 581 
mutation of the p2ry12 gene. (C) The Tg(mpeg1:mCherry; p2ry12:p2ry12-582 
GFP) double transgenic fish was utilized to facilitate in vivo observations of 583 
P2ry12 knockout. Macrophages and microglia express mCherry under the 584 
mpeg1 promoter while microglia express in addition P2ry12-GFP under the 585 
control of the p2ry12 promoter. The injection of Cas9 and the control guide 586 
RNA did neither impact on mCherry expression nor on P2ry12-GFP 587 
expression. Upon injection of Cas9 and the p2ry12 guide RNA, expression of 588 
P2ry12-GFP was effectively abolished. Representative images at 5 dpf are 589 
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shown. Images were captured using an Andor spinning disk confocal 590 
microscope with a 20x/0.75 objective. Scale bars represent 20 µm.  591 
 592 
Figure 5. P2RY12 mediated microglial interactions stimulate AKT1 cell 593 
proliferation. CRISPR/Cas9 mediated knockout of the P2y12 receptor had 594 
no impact on microglia numbers but led to significantly reduced proliferation 595 
rates of AKT1+ cells. (A) Quantification of the number of microglia in control 596 
larvae and upon AKT1 overexpression in WT and p2ry12 crispant zebrafish 597 
[Control – WT: 86.71 ± 2.34, n = 34; p2ry12-/-: 89.8 ± 3.99, n = 20] [AKT1 – 598 
WT: 148 ± 4.38, n = 45; p2ry12-/-: 133.9 ± 7.07, n = 19]. (B) Quantification of 599 
the level of proliferation of RFP-expressing cells in control larvae and upon 600 
AKT1 overexpression in WT, ctrl-gRNA and p2ry12 crispant zebrafish [Control 601 
– WT: 9.25 ± 0.75%, n = 13; ctrl-gRNA: 12.07 ± 3.16%, n = 11; P2ry12-/-: 9.92 602 
± 0.97%, n = 20] [AKT1 – WT: 57.1 ± 2.03%, n = 17; ctrl-gRNA: 59.12 ± 603 
2.18%, n = 12; P2ry12-/-: 26.8 ± 2.37%, n = 19]. Error bars represent mean ± 604 
SEM.  605 
Video Legends 606 
 607 
Video 1. Microglia responses to control RFP neural cells (REF to Fig 1). 608 
In vivo time-series showing representative microglia (green) behaviour in the 609 
presence of control neural cells (red). Images were acquired every 2 min over 610 
a duration of 180 min (3 hr) using an Andor spinning disk confocal microscope 611 
with a 20x/0.75 objective. Scale bar represents 30 µm.  612 
 613 
Video 2. Microglia display close interactions with AKT1 expressing cells 614 
(REF to Fig 1). In vivo time-series showing representative microglia (green) 615 
behaviour in the presence of AKT1 positive cells (red). In comparison to 616 
controls, the microglia were observed to keep in close contact with the AKT1 617 
expressing cells over long periods of time. Images were acquired every 2 min 618 
over a duration of 180 min (3 hr) using an Andor spinning disk confocal 619 
microscope with a 20x/0.75 objective. Scale bar represents 30 µm.  620 
 621 
Video 3. Microglia display close interactions with AKT1 expressing cells 622 
(REF to Fig 1). In vivo time-series showing representative microglia (green) 623 
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behaviour in the presence of isolated AKT1 positive cells (red). Microglia were 624 
observed to contact different oncogenic cells and to flatten their surfaces and 625 
wrap their cell bodies around the oncogenic cells over long periods of time. 626 
Images were acquired every 2 min over a duration of 180 min (3 hr) using an 627 
Andor spinning disk confocal microscope with a 20x/0.75 objective. Scale bar 628 
represents 5 µm.  629 
 630 
Video 4. Different microglia interact with the same isolated AKT1 631 
expressing cell (REF to Fig 1). In vivo time-series showing representative 632 
microglia (green) behaviour in the presence of isolated AKT1 positive cells 633 
(red). Different microglia were observed to make direct contacts with the same 634 
oncogenic cell via their extended processes over long periods of time. Images 635 
were acquired every 2 min over a duration of 180 min (3 hr) using an Andor 636 
spinning disk confocal microscope with a 20x/0.75 objective. Scale bar 637 
represents 10 µm.  638 
 639 
Video 5. Control cells show minor changes in intracellular Ca2+ levels 640 
over time (REF to Fig 2). The Tg(b-actin:GCaMP6f) transgenic line was used 641 
to monitor and measure in vivo calcium (Ca2+) activities in control RFP cells. 642 
Samples were imaged over 5 minutes (300 s) with a capture rate of 1 643 
frame/sec using an Andor spinning disk confocal microscope with a 20x/0.75 644 
objective. The data has been normalized and represented as a function of 645 
∆F/F0 plotted against time. 646 
 647 
Video 6. AKT1 cells dynamically regulate their intracellular Ca2+ levels 648 
over time (REF to Fig 2). The Tg(b-actin:GCaMP6f) transgenic line was used 649 
to monitor and measure in vivo calcium (Ca2+) activities in AKT1 cells. 650 
Samples were imaged over 5 minutes (300 s) with a capture rate of 1 651 
frame/sec using an Andor spinning disk confocal microscope with a 20x/0.75 652 
objective. The data has been normalized and represented as a function of 653 
∆F/F0 plotted against time. 654 
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